Singapore, Singapore

Romelo Gibe

This inventor holds 1 USPTO granted patent, plus 2 CIPO patents and 1 EPO patent. Top assignee: Simon Fraser University. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Romelo Gibe. Retrieved from https://idiyas.com/inventor/romelo-gibe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Romelo Gibe: Innovator in Prostaglandin-Bisphosphonate Conjugate Compounds

Introduction

Romelo Gibe is a prominent inventor based in Singapore, recognized for his contributions to the field of biochemistry. His innovative work in developing prostaglandin-bisphosphonate conjugate compounds reflects the advancements in medical chemistry that can lead to significant therapeutic applications.

Latest Patents

Romelo holds a patent for his invention titled "Prostaglandin-bisphosphonate conjugate compounds, methods of making same, and uses thereof." This patent encompasses conjugate compounds along with synthesis methods for producing these compounds and their various uses in medical applications. His work demonstrates a commitment to advancing health-related innovations through chemical research.

Career Highlights

Romelo Gibe is currently affiliated with Simon Fraser University, where he engages in pioneering research and innovation. His academic and professional journey has equipped him with the skills and knowledge necessary to contribute meaningfully to the field of medicinal chemistry.

Collaborations

Throughout his career, Romelo has collaborated with notable colleagues such as Robert N. Young and Stephen Paul Arns. These collaborations underscore the importance of teamwork in achieving groundbreaking innovations and advancing scientific knowledge.

Conclusion

Romelo Gibe's work in prostaglandin-bisphosphonate conjugate compounds exemplifies the impact of innovation in the medical field. His research not only fosters scientific progress but also holds the potential for significant advancements in therapeutic applications. The collaboration with esteemed colleagues further highlights the collective effort required in the realm of scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…